Defining Your First In-Patient Study Dose to Optimize Safety & Efficacy
Time: 11:30 am
day: Day 2 Track B AM
Details:
- Implementing a suitable dose-ranging study using appropriate preclinical scaling methods; PK and pharmacodynamic correlations
- Exploring how to determine dose parameters
- How accurate are our approaches for predicting human FIH doses?
- Key immunogenicity variables for systemic vs local administration and the resulting dosing implications
Speakers:
